Skip to main content

Ganglionic Activity of Cardiovascular Drugs

  • Chapter
Pharmacology of Ganglionic Transmission

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 53))

  • 139 Accesses

Abstract

Since the major use of ganglion-blocking drugs is in the treatment of cardiovascular disease, it is necessary to discuss the interaction between these blocking drugs and cardiovascular drugs. This section will examine three form of pharmacological actions and interactions: first, the effect of cardiovascular drugs on the autonomic ganglia; second, the influence of ganglionic blockade on the haemodynamic action of cardiovascular drugs; and third, the influence of cardiovascular drugs on the hypotensive action of ganglion-blocking drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Angeletti, P.U., Levi-Montalcini, R., Caramia, F.: Structural and ultrastructural changes in developing sympathetic ganglia induced by guanethidine. Brain Res. 43, 515–525 (1972)

    Article  PubMed  CAS  Google Scholar 

  • Aviado, D.M.: Norepinephrine. In: Sympathomimetic drugs. Springfield: Thomas 1970

    Google Scholar 

  • Barany, E.H., Treister, G.: Time relations of degeneration mydriasis and degeneration vasoconstriction in the rabbit ear after sympathetic denervation. Effect of bretylium. Acta Physiol. Scand. 80, 79–92 (1970)

    Article  PubMed  CAS  Google Scholar 

  • Black, I.B., Geen, S.C.: Trans-synaptic regulation of adrenergic neuron development: inhibition by ganglionic blockade. Brain Res. 63, 291–302 (1973)

    Article  PubMed  CAS  Google Scholar 

  • Boyajy, L.D., Nash, C.B.: Alteration of ouabain toxicity by cardiac denervation. Toxicol. Appl. Pharmacol. 9, 199–208 (1966)

    Article  PubMed  CAS  Google Scholar 

  • Burnstock, G., Evans, B., Gannon, B.J., Heath, J.W., James, V.: A new method of destroying adrenergic nerves in adult animals using guanethidine. Br. J. Pharmacol. 43, 295–301 (1971)

    PubMed  CAS  Google Scholar 

  • Caramia, F., Angeletti, P.U., Levi-Montalcini, R., Carratelli, L.: Mitochondrial lesions of developing symphatetic neurons induced by bretylium tosylate. Brain Res. 40, 237–246 (1972)

    Article  PubMed  CAS  Google Scholar 

  • Downing, O.A., Juul, P.: The effect of guanethidine pretreatment on transmission in the superior cervical ganglion. Acta Pharmacol. Toxicol. 32, 369–381 (1973)

    Article  CAS  Google Scholar 

  • Eranko, L., Eranko, O.: Effect of guanethidine on nerve cells and small intensely fluorescent cells in sympathetic ganglia of newborn and adult rats. Acta Pharmacol. Toxicol. (Kbn) 30, 403–416 (1971 a)

    Article  CAS  Google Scholar 

  • Eranko, O., Eranko, L.: Histochemical evidence of chemical sympathectomy by guanethidine in newborn rats. Histochem. J. 3, 451–456 (1971 b)

    Article  PubMed  CAS  Google Scholar 

  • Farr, W.C., Grupp, G.: Sympathetically mediated effects of angiotensin on the dog heart in situ. J. Pharmacol. Exp. Ther. 156, 528–537 (1967)

    PubMed  CAS  Google Scholar 

  • Farr, W.C., Grupp, G.: Ganglionic stimulation: mechanism of the positive inotropic and chronotropic effects of angiotensin. J. Pharmacol. Exp. Ther. 177, 48–55 (1971)

    PubMed  CAS  Google Scholar 

  • Hamer, J., Jackson, E.: The effect of ganglionic blockade on the pressor response to angiotensin in systemic hypertension. Cardiovasc. Res. 3, 411–414 (1969)

    Article  PubMed  CAS  Google Scholar 

  • Heath, J., Eranko, O., Eranko, L.: Effect of guanethidine on the ultrastructure of the small, granule-containing cells in cultures of rat sympathetic ganglia. Acta Pharmacol. Toxicol. (Kbn.) 33, 209–218 (1973)

    Article  CAS  Google Scholar 

  • Hill, C.E., Mark, G.E., Eranko, O., Eranko, L., Burnstock, G.: Use of tissue culture to examine the actions of guanethidine and 6-hydroxydopamine. Eur. J. Pharmacol. 23, 162–174 (1973)

    Article  PubMed  CAS  Google Scholar 

  • Jaramillo, J., Volle, R.L.: Ganglionic blocking properties of the diuretic agent amiloride hydrochloride. Arch. Int. Pharmacodyn. Ther. 177, 298–310 (1969)

    PubMed  CAS  Google Scholar 

  • Jenson-Holm, J., Juul, P.: The effects of guanethidine, pre- and postganglionic nerve division on the rat superior cervical ganglion: cholinesterases and catecholamines (histochemistry), and histology. Acta Pharmacol. Toxicol. (Kbn.) 28, 283–298 (1970)

    Article  Google Scholar 

  • Joh, T.H., Geghman, C., Reis, D.: Immunochemical demonstration of increased accumulation of tyrosine hydroxylase protein in sympathetic ganglia and adrenal medulla elicited by reser-pine. Proc. Natl. Acad. Sci. USA 70, 2767–2771 (1973)

    Article  PubMed  CAS  Google Scholar 

  • Juul, P.: Effects of various antihypertensive guanidine derivatives on the adult rat superior cervical ganglion: histology, ultrastructure, and Cholinesterase histochemistry. Acta Pharmacol. Toxicol. (Kbn.) 32, 500–512 (1973a)

    Article  CAS  Google Scholar 

  • Juul, P.: Accumulation of guanethidine by sympathetic ganglia of reserpinized rats. Acta Pharmacol. Toxicol. (Kbh.) 33, 79–80 (1973 b)

    Article  CAS  Google Scholar 

  • Juul, P., Mclsaac, R.L.: The effect on guanethidine on the noradrenaline content of the adult rat superior cervical ganglion. Acta Pharmacol. Toxicol. (Kbh.) 32, 382–389 (1973)

    Article  CAS  Google Scholar 

  • Juul, P., Sand, O.: Determination of guanethidine in sympathetic ganglia. Acta Pharmacol. Toxicol. (Kbh.) 32, 487–499 (1973)

    Article  CAS  Google Scholar 

  • Kato, A.C., Katz, H.S., Collier, B.: Absence of adenine nucleotide release from autonomic ganglion. Nature 249, 576–577 (1974)

    Article  PubMed  CAS  Google Scholar 

  • Keen, P., McLean, W.G.: The effect of N6, O2′-dibutyryl adenosine 3′:5′-cyclic monophosphate on noradrenaline synthesis in isolated superior cervical ganglia. Br. J. Pharmacol. 46, 529P–530P(1972)

    PubMed  CAS  Google Scholar 

  • Mueller, R.A., Thoenen, H., Axelrod, J.: Inhibition of neuronally induced tyrosine hydroxylase by nicotinic receptor blockade. Eur. J. Pharmacol. 10, 51–56 (1970)

    Article  PubMed  CAS  Google Scholar 

  • Reit, E.: Actions of angiotensin on the adrenal medulla and autonomic ganglia. Fed. Proc. 31, 1338–1343(1972)

    PubMed  CAS  Google Scholar 

  • Samwer, K.-F., Schreiber, M., Molzahn, M., Oelkers, W.: Pressor effect of angiotensin II in sodium replete and deplete rats. Relationship to plasma renin, plasma sodium, and hematocrit before and after ganglionic blockade. Pflügers Arch. 346, 307–318 (1974)

    Article  PubMed  CAS  Google Scholar 

  • Trendelenburg, U.: Some aspects of the pharmacology of autonomic ganglion cells. In: Reviews of physiology, biochemistry, and experimental pharmacology, Vol. 59. Berlin, Heidelberg, New York: Springer 1967

    Google Scholar 

  • Varagic, V.M., Zugic, M.: The effect of N6–2′-O-dibutyryl-3′,5′-cyclic adenosine monophosphate, imidazole, and aminophylline on ganglionic transmission in the superior cervical ganglion of the cat. Br. J. Pharmacol. 49, 407–414 (1973)

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Aviado, D.M. (1980). Ganglionic Activity of Cardiovascular Drugs. In: Kharkevich, D.A. (eds) Pharmacology of Ganglionic Transmission. Handbook of Experimental Pharmacology, vol 53. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67397-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-67397-9_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-67399-3

  • Online ISBN: 978-3-642-67397-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics